Asparaginase injection ultimately reduces the levels of asparagine. Some leukemic cells are unable to synthesize asparagine because of lack of asparagine synthetase. As a result, depletion of asparagine selectively kills the malignant cells. The injection is usually given as powder for solution 10,000 units. Asparaginase is classified as an antineoplastic agent.